跳至主要内容
临床试验/NL-OMON42160
NL-OMON42160撤回不适用

Palliation of Obstructive Local Disease of the Esophagus by Radiotherapy - POLDER study

Academisch Medisch Centrum0 个研究点目标入组 210 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
入组人数
210

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Histological proven large cell carcinoma of the esophagus
  • M+ disease stage or patients otherwise not a candidate for curative locoregional treatment
  • Life expectancy * 3 months
  • Dysphagia grade *2
  • Written study-specific informed consent at the time of registration

排除标准

  • Age <18 years
  • Macro- or microscopic tumour growth into the tracheal lumen, or suspicion of ingrowth.
  • Tumour length of more than 12 cm, including multifocal tumors over a length of more than 12 cm.
  • Prior radiotherapy to the oesophagus/mediastinum more than 20 Gy or any prior brachytherapy to the oesophagus.
  • (partial) resection of the oesophagus
  • Chemotherapy for esophageal cancer <6 weeks prior to (or during) radiotherapy
  • Esophageal stent in situ
  • Tumoral extension of > 4 cm in the cardia of the stomach
  • CT-thorax more than 3 months before start of treatment
  • Intraluminal brachytherapy medically or technically not possible
  • Inability to understand the nature and possible consequences of the study or unwilling to undergo follow-up assessments.

研究者

相似试验